课题基金 / 基金详情

Pre-Chemotherapeutic Care of HCV Infected Drug Users

Pre-Chemotherapeutic Care of HCV Infected Drug Users
HCV 感染吸毒者的化疗前护理
批准号:
7479701
负责人:
DAWN A FISHBEIN
金额:
$17.6万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2009-07-31

项目摘要

项目成果

DAWN A FISHBEIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): The care of chronic hepatitis C (HCV) infection among drug users, many of whom are co-infected with HIV, is an important public health problem. For drug users with chronic HCV infection, alcohol and active drug abuse, high rates of depression, susceptibility to hepatitis A and B infections, and HIV co-infection are only a few of the variables that affect engagement in and outcome of HCV chemotherapy. Attention to these "pre-chemotherapeutic" factors prepares drug users for future and possibly more efficacious HCV chemotherapy. However, little is known about whether these "pre-chemotherapeutic" factors are successfully addressed in the context of chronic HCV management. The candidate proposes the following specific aims: 1) To determine rates of engagement in pre-chemotherapeutic care among drug users with chronic HCV infection. 2) To determine factors associated with awareness and acceptance of interventions other than specific chemotherapy for reducing the progression of chronic HCV infection and preparing for future chemotherapy. The candidate proposes a five-year prospective study of engagement in and factors associated with pre-chemotherapeutic care for hepatitis C infection, among HCV-infected drug users participating in two ongoing cohort studies of men and women with or at risk for HIV. Participants will be screened and enrolled at a semi-annual research visit for the parent studies. At each semi-annual research visit, study participants will undergo standardized interviews to gather data on demographics, sexual and drug-using behaviors and medical history, including symptoms of and treatment for hepatitis. In addition, blood will be drawn for laboratory assays including HCV antibody and HCV RNA levels. The purpose of this K23 grant proposal is to support this candidate as she develops her clinical research career and undertakes studies in HCV-infected drug users with or at risk for HIV, under the mentorship of experienced investigators.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1365-2036.2009.04004.x
发表时间: 2009-07
期刊: Alimentary pharmacology & therapeutics
影响因子: 7.6
作者: [Weiss JJ, Bräu N, Stivala A, Swan T, Fishbein D]
通讯作者: Fishbein D
Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection.
血管紧张素转换酶抑制剂对 HIV 和丙型肝炎合并感染肝纤维化的影响。
DOI: 10.1155/2012/978790
发表时间: 2012
期刊: AIDS research and treatment
影响因子: 1.7
作者: [Reese,LindseyJ, Tider,DianeS, Stivala,AliciaC, Fishbein,DawnA]
通讯作者: Fishbein,DawnA
DOI: 10.1080/10550887.2010.509281
发表时间: 2010-10
期刊: Journal of addictive diseases
影响因子: 2.3
作者: [Felsen UR, Fishbein DA, Litwin AH]
通讯作者: Litwin AH
HIV and Hepatitis B Virus Coinfection: Approach to Management: Case Study and Commentary.
HIV 和乙型肝炎病毒合并感染:管理方法:案例研究和评论。
DOI: --
发表时间: 2010
期刊: Journal of clinical outcomes management : JCOM
影响因子: --
作者: [Chasan,Rachel, Reese,Lindsey, Fishbein,Dawn]
通讯作者: Fishbein,Dawn
EARLY IDENTIFICATION AND LINKAGE TO CARE FOR PERSONS WITH CHR
EARLY IDENTIFICATION AND LINKAGE TO CARE FOR PERSONS WITH CHR
PROTECTIVE IMMUNITY TO HBV IN HIV+ PATIENTS WITH ISOLATED HEPATITIS B
PROTECTIVE IMMUNITY TO HBV IN HIV+ PATIENTS WITH ISOLATED HBV CORE ANTIBODY
海外基金